Position in IMTX
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$8,075,855
+$572,881 QoQ
Shares Held
820,717
+14.9% QoQ
Ownership
0.600%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IMTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Aberdeen Group plc holds $1,803,580,461 across 84 Biotechnology names. IMTX ranks #54 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
233,480 | $104,258,157 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,344 | $93,755,226 | |
| 3 | IMUX |
Immunic, Inc.
|
8,243,941 | $91,507,745 | |
| 4 | QURE |
uniQure N.V.
|
5,306,386 | $86,759,411 | |
| 5 | MANE |
Veradermics, Inc
|
1,054,660 | $66,601,779 | |
| 6 | ARGX |
Argenx SE
|
82,106 | $59,957,906 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
978,969 | $56,887,888 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
172,484 | $55,572,619 |
All Filings in IMTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,075,855 | 820,717 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $7,502,974 | 714,569 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $6,726,079 | 789,446 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $3,871,372 | 719,586 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $3,245,332 | 719,586 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,469,864 | 347,379 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $2,657,389 | 232,900 | Shares | Defined | 2024-10-25 | |
| No filing history on record for this holder in this stock. | ||||||